2020
DOI: 10.1053/j.gastro.2019.11.295
|View full text |Cite
|
Sign up to set email alerts
|

Lactotrehalose, an Analog of Trehalose, Increases Energy Metabolism Without Promoting Clostridioides difficile Infection in Mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
35
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 28 publications
(35 citation statements)
references
References 69 publications
0
35
0
Order By: Relevance
“…Secondly, it was shown that compared to a water control, oral dosing with trehalose increased the risk of disease 3-fold [ 50 ]. Additionally, a recent study [ 52 ] has shown that feeding trehalose or lactotrehalose (a trehalase-resistant form of trehalose) did not promote growth of C. difficile CD027 in mice, and actually reduced the levels of markers of inflammation in gut issues. It is not clear why the results of this study are different to the previously reported effects of trehalose on the potentiation of C. difficile disease.…”
Section: Introductionmentioning
confidence: 99%
“…Secondly, it was shown that compared to a water control, oral dosing with trehalose increased the risk of disease 3-fold [ 50 ]. Additionally, a recent study [ 52 ] has shown that feeding trehalose or lactotrehalose (a trehalase-resistant form of trehalose) did not promote growth of C. difficile CD027 in mice, and actually reduced the levels of markers of inflammation in gut issues. It is not clear why the results of this study are different to the previously reported effects of trehalose on the potentiation of C. difficile disease.…”
Section: Introductionmentioning
confidence: 99%
“…18,19 Both of these adapted trehalose utilization mechanisms were shown to provide in vitro growth advantages to C. difficile, which led to the hypothesis that escalating consumption of trehalose by humans may have contributed to the spread and virulence of these epidemic C. difficile strains over the past two decades. 18,19,23 However, the available evidence from mouse infection models 18,19,24 is mixed and, along with human epidemiology data, 25,26 does not unequivocally support this hypothesis. Whereas some reports 18,19 suggested that trehalose enhanced RT027 disease severity via toxin elevation, these data are counterbalanced by mouse infection models showing that trehalose did not increase RT027 disease severity, bacterial burden, toxin level, or colorectal inflammation.…”
Section: Importance Of Trehalose To Bacterial Physiology and Virulencementioning
confidence: 99%
“…Whereas some reports 18,19 suggested that trehalose enhanced RT027 disease severity via toxin elevation, these data are counterbalanced by mouse infection models showing that trehalose did not increase RT027 disease severity, bacterial burden, toxin level, or colorectal inflammation. 24 Further investigation is needed to assess the potential contributions of trehalose metabolism to C. difficile infection and, correspondingly, its potential as a therapeutic target. In the meantime, these studies illustrate the diversity of trehalose metabolic pathways that occur and evolve in bacteria, even between different strains of the same species, and also call attention to the possibility that trehalose consumption can impact the trehalose-metabolizing population of the human microbiota.…”
Section: Importance Of Trehalose To Bacterial Physiology and Virulencementioning
confidence: 99%
See 1 more Smart Citation
“…The bioavailability of ingested trehalose is low [ 8 , 9 ] and may depend on bacteria colonization [ 10 ]. Nevertheless, trehalose-based diets in mice have positive cardiometabolic [ 4 , 11 , 12 ], neuroprotective [ 13 ], and anti-inflammatory properties [ 14 ].…”
Section: Introductionmentioning
confidence: 99%